Southeast Asia Covid-19 Vaccine Tracker: Who Will Get What, When
Southeast Asia Covid-19 Vaccine Tracker: Who Will Get What, When
(Bloomberg) -- In the race to immunize people against the coronavirus, Singapore has pulled ahead of its neighbors to become the first in Southeast Asia to start an official Covid-19 vaccination program.
The city-state began inoculating healthcare workers on Dec. 30, when it gave shots to 40 staff from its national infectious diseases center.
Indonesia, which was the first in the region to receive a vaccine shipment, needs to wait for more data before approving China’s Sinovac Biotech Ltd. shots for use. Southeast Asia’s biggest and most populous economy has announced multiple agreements to receive potential vaccines as the nation fights the region’s worst coronavirus outbreak.
Read Bloomberg‘s latest Covid Resilience Ranking
Both countries are involved in vaccine development and manufacturing, a testament to the variety of strategies employed by Southeast Asian nations. Here’s how the region of more than 650 million people is dealing with differing fiscal, demographic and distribution challenges in their vaccine strategies.
INDONESIA | |
Strategy | Indonesia seeks to vaccinate 181.5 million people, prioritizing those aged 18 to 59 years old.
|
Timeline | 1Q 2021: Sinovac
2Q 2021: AstraZeneca
|
PHILIPPINES | |
Strategy | The country wants to have at least 50 million vaccine shots next year to inoculate about a fourth of the population, the bulk of which will likely arrive by the end of 2021 or early 2022. Priority for vaccinations will be given to medical frontliners and workers in industries deemed critical, including low-income groups and those identified as at risk.
|
Timeline | 1Q 2021: Sinovac, Sputnik V
May 2021: AstraZeneca
|
MALAYSIA | |
Strategy | The country is spending $504 million to buy enough shots to cover 26.5 million people, or about 80% of its population.
|
Timeline | 1Q 2021: Pfizer
|
SINGAPORE | |
Strategy | The city-state has set aside roughly S$1 billion ($754 million) for vaccines, tapping the likes of Arcturus Therapeutics Holdings Inc., Moderna Inc., Pfizer and Sinovac for supplies. It estimates it should have enough for its around 5.5 million-strong population by the third quarter of 2021.
|
Timeline | 4Q 2020: Pfizer
Early 2021: Arcturus
|
THAILAND | |
Strategy | Thailand wants to inoculate about 50% of its population by next year. It plans to get 26 million doses from the World Health Organization-backed Covax program, 26 million from AstraZeneca, and 13 million more from other sources, providing immunity to more than 30 million people. Not wanting to rely solely on inoculations from abroad, Thailand is also developing its own anti-coronavirus shot.
|
Timeline | Mid-2021: AstraZeneca
|
VIETNAM | |
Strategy | The country is working on developing vaccines and will work with suppliers when vaccines are available, according to a spokeswoman at the foreign affairs ministry.
|
©2020 Bloomberg L.P.